论文部分内容阅读
目的探讨血液透析联合血液灌流治疗肾性骨病的临床应用效果。方法 100例肾性骨病患者,按照治疗方式的不同分为对照组和观察组,每组50例。对照组患者单纯使用血液透析的方式进行治疗,观察组患者在对照组治疗的基础上加用血液灌流的方式进行治疗,观察经过治疗后两组患者血钙、血磷和血全段甲状腺旁素(iPTH)情况,比较两组患者治疗的总有效率。结果经过治疗后,对照组患者治疗的总有效率为80%;观察组为98%,两组比较差异具有统计学意义(P<0.05)。治疗前两组血钙、血磷和血i PTH比较差异无统计学意义(P>0.05),治疗后观察组上述指标优于对照组,差异有统计学意义(P<0.05)。结论血液透析联合血液灌流治疗肾性骨病能够有效提高治疗的总有效率情况,改善患者的血钙、血磷、血i PTH,具有较强的临床应用价值。
Objective To investigate the clinical effect of hemodialysis combined with hemoperfusion on renal osteodystrophy. Methods 100 patients with renal osteodystrophy were divided into control group and observation group according to the different treatment methods, 50 cases in each group. Patients in the control group were treated with hemodialysis only. Patients in the observation group were treated with hemoperfusion on the basis of the control group. The levels of serum calcium, phosphorus and whole blood thyroid parathyroid hormone (iPTH), comparing the total effective rate of treatment in both groups. Results After treatment, the total effective rate was 80% in the control group and 98% in the observation group. The difference between the two groups was statistically significant (P <0.05). There was no significant difference in serum calcium, serum phosphorus and blood i PTH between the two groups before treatment (P> 0.05). The above indexes in the observation group were better than those in the control group after treatment (P <0.05). Conclusion Hemodialysis combined with hemoperfusion treatment of renal osteodystrophy can effectively improve the total effective rate of treatment, and improve the blood calcium, phosphorus, blood i PTH, has a strong clinical value.